- Home
- AURA vs EIKN Comparison
AURA vs EIKN Comparison
Compare AURA & EIKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$6.41
N/A
Current Price
$8.85
Company Overview
Basic Information| Metric | AURA | EIKN |
|---|---|---|
| Founded | 2007 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 713.4M | 731.6M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | AURA | EIKN |
|---|---|---|
| Price | $6.41 | $8.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $20.00 | ★ $25.60 |
| AVG Volume (30 Days) | ★ 448.1K | 296.8K |
| Earning Date | 05-08-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.73 | $7.90 |
| 52 Week High | $9.54 | $16.50 |
Technical Indicators
Market Signals| Indicator | AURA | EIKN |
|---|---|---|
| Relative Strength Index (RSI) | 35.73 | 41.74 |
| Support Level | $5.81 | $8.48 |
| Resistance Level | $6.56 | $12.16 |
| Average True Range (ATR) | 0.34 | 0.90 |
| MACD | -0.13 | -0.18 |
| Stochastic Oscillator | 19.95 | 25.00 |
Price Performance
Historical Comparison AURA
EIKN
About AURA Aura Biosciences Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.